Analyst Ratings for Evolent Health (EVH)
EVH Rating Summary
EVH Price Target Summary
- Highest: $10.00 (Citizens)
- Lowest: $3.00 (RBC Capital)
- Average: $6.08
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$6.08 (+42.1%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 85%
Avg. $ Target:
$6.08 (+42.1%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/10/2026 | Citi | Daniel Grosslight | Upgrade | Buy (Neutral) |
6.00 (6.75) |
3.95 (4.28) |
8.35% | Details |
| 6/30/2026 | Truist Securities » Updated 8/12/2026 |
Jailendra Singh | Downgrade | Hold (Buy) |
6.00 (7.00) |
5.51 (4.28) |
-22.32% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


